Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

76. Hughes K M, Johnson P N, Anderson M, Sekar K C, Welliver R C, Miller J L. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2017; 22 : 33-40

77. Capino A C, Miller J L, Johnson P N. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016; 36 : 1290-1299

78. Ibach B W, Johnson P N, Ernst K D, Harrison D, Miller J L. Initial dosing and taper complexity of methadone and morphine for treatment of neonatal abstinence syndrome. Journal of Pharmacy Technology. 2016; 32 : 216-22

79. Johnson P N, Miller J L, Hagemann T M, Moffett B S. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2016; 73 : 1243-9

80. Van Tuyl J S, Jones A N, Johnson P N. Meropenem-Induced Neutropenia in a Neonate. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2016; 21 : 353-357

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.


4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.


5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results